Company: CRLBF
Filing Date: 2025-08-20
Form Type: SC TO-I
Source: 0001832928-25-000022
Chunk: 2

Company: Cresco Labs Inc.
Filing Date: 2025-08-20
Form: SC TO-I
Chunk 2
---
 the Offer to Exchange under the headings “ Summary Term Sheet—Overview ” and “ Summary Term Sheet—Questions and Answers ” and the information set forth under Section 1 (“ Eligible Participants; Eligible Options; the Proposed Exchange; Expiration and Extension of the Exchange Offer ”) of the Offering Memorandum for the Exchange Offer contained in the Offer to Exchange (the “ Offering Memorandum ”) is incorporated herein by reference.

(c) Trading Market and Price . The information set forth under Section 7 (“ Price Range of Our Common Shares ”) of the Offering Memorandum is incorporated herein by reference.

## ITEM 3. Identity and Background of Filing Person.
(a) The Company is the filing person and issuer. The information set forth under Item 2(a) of this Schedule TO is incorporated herein by reference. Pursuant to General Instruction C to Schedule TO, the following persons are the directors and/or executive officers of the Company:

| Name               |     | Position                             |
| Charles Bachtell   |     | Chief Executive Officer and Director |
| Sharon Schuler     |     | Chief Financial Officer              |
| Greg Butler        |     | President                            |
| Angie Demchenko    |     | Chief People Officer                 |
| Zach Marburger     |     | Chief Information Officer            |
| John Schetz        |     | General Counsel                      |
| Thomas J. Manning  |     | Chairman of the Board of Directors   |
| Gerald F. Corcoran |     | Director                             |
| Robert M. Sampson  |     | Director                             |
| Randy D. Podolsky  |     | Director                             |
| Marc Lustig        |     | Director                             |
| Michele Roberts    |     | Director                             |

The business address and telephone number for all of the above directors and executive officers is: c/o Cresco Labs Inc. 600 West Fulton Street, Suite 800, Chicago, IL 60661, (312) 929-0993.

There is neither any person controlling the Company nor any executive officer or director of any corporation or other person ultimately in control of the Company.

## ITEM 4. Terms of the Transaction.
(a) Material Terms . The information set forth in the Offer to Exchange under the headings “Summary Term Sheet—Overview” and “ Summary Term Sheet—Questions and Answers ” and the information set forth under Section 1 (“ Eligible Participants; Eligible Options; the Proposed Exchange; Expiration and Extension of the Exchange Offe r”) , Section 3 (“ Procedures